Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia

NCT06749444 is registered in ClinicalTrials.gov with Jimmi Nielsen as lead sponsor.

NCT NCT06749444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06749444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia
Lead sponsor
Jimmi Nielsen
Phase
Not applicable
Overall status
Recruiting
Start date
November 28, 2024
Completion date
April 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-refractory schizophrenia, treatment-resistant schizophrenia